Загрузка...
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms
Patients with myeloproliferative neoplasms (MPNs), polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have an increased risk of thrombosis. Risk of recurrent thrombosis can be reduced with antithrombotic therapy and/or cytoreduction, but the optimal long-term management in pati...
Сохранить в:
| Опубликовано в: : | Blood Adv |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805324/ https://ncbi.nlm.nih.gov/pubmed/33570633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003628 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|